Science Explorer Back to mapMap
Discussion
Company · 's-Hertogenbosch · Netherlands

PamGene (Netherlands)

pamgene.comROR OpenAlex
Research works
66
▼ 54% vs 2018-21
Citations
1.5k
22.4 per fractional work
Top-10% rate
5.1%
all institutions 10.0%
Open access
49%
world 40%
International
48%
world 18%
PamGene (Netherlands)

Not ranked overall: PamGene (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PamGene (Netherlands) work in?

In all years, 53% of research at PamGene (Netherlands) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Medicine (36%), Chemistry (5%). It does 3.0× the world's share of Life Sciences.

Life Sciences: 35 fractional works · 53.3% of its workBiochemistry, Genetics and Molecular Biology: 30 fractional works · 44.7% of its workMolecular Biology: 20 fractional works · 30.7% of its workGenetics: 4 fractional works · 6.3% of its workCancer Research: 3 fractional works · 4.0% of its workCell Biology: 1 fractional works · 1.7% of its workBiotechnology: 1 fractional works · 1.1% of its workBiochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workImmunology and Microbiology: 3 fractional works · 4.8% of its workImmunology: 3 fractional works · 4.8% of its workNeuroscience: 2 fractional works · 2.8% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.9% of its workBehavioral Neuroscience: 0 fractional works · 0.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.8% of its workAgronomy and Crop Science: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workHealth Sciences: 24 fractional works · 36.5% of its workMedicine: 24 fractional works · 35.9% of its workOncology: 7 fractional works · 10.5% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 5.4% of its workPulmonary and Respiratory Medicine: 3 fractional works · 4.5% of its workHematology: 1 fractional works · 1.9% of its workPhysiology: 1 fractional works · 1.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.7% of its workGenetics: 1 fractional works · 1.7% of its workDermatology: 1 fractional works · 1.5% of its workPathology and Forensic Medicine: 1 fractional works · 1.1% of its workOphthalmology: 1 fractional works · 0.9% of its workNeurology: 1 fractional works · 0.9% of its workImmunology and Allergy: 1 fractional works · 0.8% of its workEpidemiology: 0 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workSurgery: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.1% of its workPhysical Sciences: 7 fractional works · 9.8% of its workChemistry: 3 fractional works · 5.2% of its workOrganic Chemistry: 2 fractional works · 2.9% of its workSpectroscopy: 2 fractional works · 2.3% of its workComputer Science: 1 fractional works · 1.5% of its workComputational Theory and Mathematics: 1 fractional works · 1.5% of its workEngineering: 1 fractional works · 1.3% of its workBiomedical Engineering: 1 fractional works · 1.3% of its workEnvironmental Science: 1 fractional works · 1.2% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.6% of its workMaterials Chemistry: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKPamGene(Netherlands)66fractional works, all years
Life Sciences53%Physical Sciences10%Health Sciences37%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3044.7%
    2. Immunology and Microbiology34.8%
    3. Neuroscience22.8%
    4. Agricultural and Biological Sciences10.8%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Medicine2435.9%
    2. Veterinary00.3%
    3. Nursing00.3%
    4. Health Professions00.1%
    1. Chemistry35.2%
    2. Computer Science11.5%
    3. Engineering11.3%
    4. Environmental Science11.2%
    5. Materials Science00.6%
    1. Business, Management and Accounting00.1%
    2. Decision Sciences00.1%
    3. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 8.25× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 8.61× its world share, 1 worksImmunology and Micro…Neuroscience: 0.76× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.40× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.30× its world share, 0 worksChemistryComputer Science: 0.64× its world share, 0 worksComputer ScienceEnvironmental Science: 0.29× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.36× its world share, 0 worksHealth ProfessionsMedicine: 1.81× its world share, 3 worksMedicineNursing: 2.57× its world share, 0 worksNursingVeterinary: 6.96× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.6×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology8.61×1 works
  2. Biochemistry, Genetics and Molecular Biology8.25×4 works
  3. Veterinary6.96×0 works
  4. Pharmacology, Toxicology and Pharmaceutics3.40×0 works
  5. Nursing2.57×0 works
  6. Medicine1.81×3 works
  7. Neuroscience0.76×0 works
  8. Computer Science0.64×0 works
  9. Health Professions0.36×0 works
  10. Chemistry0.30×0 works
  11. Environmental Science0.29×0 works

Who are the top researchers at PamGene (Netherlands)?

Ranked on the quality score, René Houtman, Riet Hilhorst and Diana Melchers lead among researchers whose main affiliation is PamGene (Netherlands).

  1. 1 René Houtman Netherlands · #490,757 worldwide 3.9k citations · 168 works
  2. 2 Riet Hilhorst Netherlands · #1,148,875 worldwide 3.2k citations · 160 works
  3. 3 Diana Melchers Netherlands · #1,367,020 worldwide 1.1k citations · 59 works
  4. 4 Savithri Rangarajan Netherlands · #1,856,007 worldwide 1.2k citations · 24 works
  5. 5 Rinie van Beuningen Netherlands · #1,873,444 worldwide 654 citations · 23 works
  6. 6 Liesbeth Houkes Netherlands · #2,664,081 worldwide 132 citations · 17 works
  7. 7 Dirk Pijnenburg Netherlands · #2,705,332 worldwide 350 citations · 43 works
  8. 8 Piet J. Boender Netherlands · #3,801,278 worldwide 730 citations · 53 works
  9. 9 Rik de Wijn Netherlands · #3,928,634 worldwide 463 citations · 74 works
  10. 10 Rob Ruijtenbeek Netherlands · #5,921,118 worldwide 1.6k citations · 152 works
All ranked researchers at PamGene (Netherlands)

What are the most cited papers from PamGene (Netherlands)?

The most cited paper from PamGene (Netherlands) is "Short-Chain Fatty Acids Stimulate Angiopoietin-Like 4 Synthesis in Human Colon Adenocarcinoma Cells by Activating Peroxisome Proliferator-Activated Receptor γ" (Sheril Alex, Katja Lange, Tom Amolo et al., 2013), with 302 citations. Next come "Triple‐negative breast cancer: Present challenges and new perspectives" (301) and "TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer" (291).

Most cited papers
#PaperReleasedCitations
1 Short-Chain Fatty Acids Stimulate Angiopoietin-Like 4 Synthesis in Human Colon Adenocarcinoma Cells by Activating Peroxisome Proliferator-Activated Receptor γ Sheril Alex, Katja Lange, Tom Amolo et al. · Molecular and Cellular Biology Open access 23 Jan 2013 302
2 Triple‐negative breast cancer: Present challenges and new perspectives Franca Podo, L.M.C. Buydens, Hadassa Degani et al. · Molecular Oncology Open access 24 Apr 2010 301
3 TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer Anna C. Groner et al. · Cancer Cell Open access 27 May 2016 291
4 Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone’s Antifibrotic Activity Jana Grune, Niklas Beyhoff, Elia Smeir et al. · Hypertension Open access 5 Feb 2018 289
5 Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations Rinath M. Jeselsohn et al. · Cancer Cell Open access Feb 2018 288
All 60 most cited papers, with filters and sorting

Which keywords describe research at PamGene (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Breast Cancer, Nuclear Receptors, Glycosylation, Signaling, Inflammation and Chemotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer7▲ 8.0×19 topics
  2. Transcriptional Regulation7▲ 40×7 topics
  3. Inflammation6▲ 3.8×22 topics
  4. Breast Cancer5▲ 29×4 topics
  5. Nuclear Receptors5▲ 43×5 topics
  6. Glycosylation5▲ 35×3 topics
  7. Signaling5▲ 63×4 topics
  8. Chemotherapy4▲ 8.6×7 topics
  9. Receptor4▲ 81×2 topics
  10. Estrogen4▲ 72×1 topic
  11. Gene Expression4▲ 8.9×8 topics
  12. Glucocorticoids4▲ 97×1 topic
  13. Machine Learning4▲ 2.4×4 topics
  14. Immunotherapy3▲ 7.4×9 topics
  15. High-Throughput Analysis3▲ 102×1 topic
  16. Protein Microarrays3▲ 235×1 topic
  17. Cancer Therapy3▲ 7.2×10 topics
  18. Fc Receptors3▲ 44×1 topic
  19. Therapeutic Antibodies3▲ 34×1 topic
  20. Tumor Microenvironment3▲ 13×7 topics
  21. Prognostic Factors3▲ 8.9×8 topics
  22. Data Analysis3▲ 12×3 topics
  23. Targeted Therapy3▲ 18×5 topics
  24. Metastatic2▲ 58×2 topics
  25. Normalization2▲ 50×2 topics
  26. Precision Medicine2▲ 11×3 topics
  27. Angiogenesis2▲ 8.2×6 topics
  28. Immune System2▲ 10×2 topics
  29. BRAF Mutation2▲ 44×2 topics
  30. Drug Discovery2▲ 7.6×4 topics
  31. Quantitative Analysis2▲ 18×2 topics
  32. Differential Expression2▲ 96×1 topic
  33. Glycans2▲ 35×1 topic
  34. Microarray2▲ 96×1 topic
  35. Monoclonal Antibody2▲ 40×2 topics
  36. Mucins2▲ 35×1 topic
  37. Cell Signaling2▲ 8.1×5 topics
  38. Immune Regulation2▲ 20×3 topics
  39. Molecular Subtypes2▲ 31×2 topics
  40. Protein-Protein Interactions2▲ 25×3 topics

Which research topics does PamGene (Netherlands) publish most on?

By volume in 2022-now: Colorectal Cancer Treatments and Studies, 14-3-3 protein interactions, Bioinformatics and Genomic Networks and Estrogen and related hormone effects.

Colorectal Cancer Treatments and Studies: 1 fractional works14-3-3 protein interactions: 1 fractional worksBioinformatics and Genom…1Bioinformatics and Genomic Networks: 1 fractional worksEstrogen and related hor…0Estrogen and related hormone effects: 0 fractional worksinterferon and immune responses: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksProtein Degradation and …0Protein Degradation and Inhibitors: 0 fractional worksRetinal Diseases and Treatments: 0 fractional worksRetinal Development and Disorders: 0 fractional worksS100 Proteins and Annexins: 0 fractional works
OncologyMolecular BiologyGeneticsImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Colorectal Cancer Treatments and Studies Oncology 1 works
  2. 2 14-3-3 protein interactions Molecular Biology 1 works
  3. 3 Bioinformatics and Genomic Networks Molecular Biology 1 works
  4. 4 Estrogen and related hormone effects Genetics 0 works
  5. 5 interferon and immune responses Immunology 0 works
  6. 6 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  7. 7 Protein Degradation and Inhibitors Molecular Biology 0 works
  8. 8 Retinal Diseases and Treatments Ophthalmology 0 works
  9. 9 Retinal Development and Disorders Molecular Biology 0 works
  10. 10 S100 Proteins and Annexins Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.9%not open51.1%

World: 40% of research is openly available.

with international co-authors47.8%domestic only52.2%

World: 18% is written across borders.

How has PamGene (Netherlands)'s research output changed?

Output in 2022-2025 was 54% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PamGene (Netherlands) as a percentage of every work published that year, 0.000012% in 2024.

still counting0.00010%0.00020%PamGene (Netherlands)0.000050% in 20251990200020102020

Fractional works of PamGene (Netherlands) over all fractional works that year. How the balance of science has shifted.

Other research institutions in 's-Hertogenbosch

All research institutions in 's-Hertogenbosch

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PamGene (Netherlands). Posts are plain text and can be reported.